![]() |
|
|
Vol. 283, Issue 1, 366-374, 1997
Department of Physiology and Department of Biochemistry and
Molecular Biology, Colorado State University, Fort Collins, Colorado
Neural disturbances are observed in the peripheral and central nervous
systems of patients with insulin-dependent diabetes mellitus (IDDM) and
non-IDDM (NIDDM). Insulin-like growth factors (IGFs) are neurotrophic
growth factors that can support nerve regeneration and neuronal
survival in the types of neurons known to be afflicted in diabetes. We
tested the hypotheses that IGF gene expression is reduced in neural
tissues and liver of spontaneously diabetic obese Zucker
(fa/fa) rats and that IGF treatment can prevent
neuropathy. There was a significant early reduction in IGF-II mRNA
content as measured per mg of wet tissue or per poly(A)+
RNA in sciatic nerves, spinal cord and brain from spontaneously diabetic obese (fa/fa) vs.
nondiabetic lean (+/+) adult rats. In addition,
IGF-I mRNA content was reduced in liver but not nerve or spinal cord of
NIDDM rats. Pain/pressure thresholds were abnormal (hyperalgesia) in
diabetic (fa/fa) vs. nondiabetic (+/+) rats, and
subcutaneous infusion of IGF-II restored thresholds toward normal. The
low dose of IGF-II that prevented hyperalgesia in contrast had no
effect on hyperglycemia or obesity. These data suggest that IGF
treatment may provide rational therapy for diabetic neuropathy and that
therapy may be effective even in patients unable to adequately control
their hyperglycemia.
This article has been cited by other articles:
![]() |
R. M. Pabbidi, D.-S. Cao, A. Parihar, M. E. Pauza, and L. S. Premkumar Direct Role of Streptozotocin in Inducing Thermal Hyperalgesia by Enhanced Expression of Transient Receptor Potential Vanilloid 1 in Sensory Neurons Mol. Pharmacol., March 1, 2008; 73(3): 995 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain Endocr. Rev., December 1, 2005; 26(7): 916 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kennedy and D. W. Zochodne Experimental Diabetic Neuropathy With Spontaneous Recovery: Is There Irreparable Damage? Diabetes, March 1, 2005; 54(3): 830 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-R. Chen and H.-L. Pan Up-Regulation of Spinal Muscarinic Receptors and Increased Antinociceptive Effect of Intrathecal Muscarine in Diabetic Rats J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 676 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-J. Huang, S. A. Price, L. Chilton, N. A. Calcutt, D. R. Tomlinson, A. Verkhratsky, and P. Fernyhough Insulin Prevents Depolarization of the Mitochondrial Inner Membrane in Sensory Neurons of Type 1 Diabetic Rats in the Presence of Sustained Hyperglycemia Diabetes, August 1, 2003; 52(8): 2129 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R H M King The role of glycation in the pathogenesis of diabetic polyneuropathy Mol. Pathol., December 1, 2001; 54(6): 400 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishiyama, D. N. Ishii, P. H. Backx, B. E. Pulford, B. R. Birks, and M. M. Tamkun Altered K+ channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv1.4 Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1800 - H1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kennedy and D. W. Zochodne The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms Brain, October 1, 2000; 123(10): 2118 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. OBROSOVA, C. VAN HUYSEN, L. FATHALLAH, X. CAO, M. J. STEVENS, and D. A. GREENE Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense FASEB J, August 1, 2000; 14(11): 1548 - 1558. [Abstract] [Full Text] |
||||
![]() |
J. R Kersten, P. S Pagel, W. M Chilian, and D. C Warltier Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia Cardiovasc Res, July 1, 1999; 43(1): 44 - 57. [Abstract] [Full Text] [PDF] |
||||